Marion General Hospital

Marion, Ohio 43303

0 studies enrolling now · 3 studies all time

What they study most

Colorectal Cancer, HER2-negative Breast Cancer, Lynch Syndrome, Rectal Cancer

Studies at this site

• Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling — Status unconfirmed
• Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer — Completed
• Ohio Colorectal Cancer Prevention Initiative — Completed